Fragile X mental retardation protein (FMRP) represses the transcription of many target genes, including genes that encode chromatin-associated proteins. Loss of FMRP leads to fragile X syndrome (FXS); however, whether misregulation of chromatin-associated proteins contributes to FXS is unclear. Korb et al. showed that neurons from mice that lack FMRP have increased levels of several chromatin-associated proteins, including bromodomain-containing protein 4 (BRD4). Inhibition of BRD4 using the small molecule JQ1 reversed many of the gene expression changes observed in the FMRP-null neurons, and rescued memory and social deficits in FXS mice.